Iason
Curium Austria specializes in the development, manufacturing, and distribution of radiopharmaceutical products, focusing on quality and innovation in nuclear medicine. With a strong presence in Europe, the company integrates advanced technologies and maintains high standards to improve patient outcomes. Their portfolio includes a range of PET radiopharmaceuticals, and they are committed to expanding their offerings and leveraging AI for better diagnostics and treatment solutions. Curium Austria aims to redefine cancer care and enhance the quality of life for patients through effective nuclear medicine solutions.
Iason
Curium Austria specializes in the development, manufacturing, and distribution of radiopharmaceutical products, focusing on quality and innovation in nuclear medicine. With a strong presence in Europe, the company integrates advanced technologies and maintains high standards to improve patient outcomes. Their portfolio includes a range of PET radiopharmaceuticals, and they are committed to expanding their offerings and leveraging AI for better diagnostics and treatment solutions. Curium Austria aims to redefine cancer care and enhance the quality of life for patients through effective nuclear medicine solutions.